Memantine is the first in a novel class of Alzheimer’s disease medications acting on the glutamatergic system by blocking NMDA receptors. It was first synthesized by Eli Lilly and Company in 1968 as a potential agent to treat diabetes; the NMDA activity was discovered in the 1980s.
API's & Drug Standards
|Formula||C12H21N · HCl|
|Appearance||crystalline powder white|
|Storage Conditions||room temperature|
Send us your enquiry for Memantine hydrochloride. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Memantine hydrochloride email us and we will include your contribution on the website.